22 . 11 .2021
Press release
Galderma leads oral presentation on hyaluronic acid filler safety insights at ASDS 2021 Annual Meeting
30 . 09 .2021
Press release
RESTYLANE®, the original stabilized hyaluronic acid filler, celebrates 25 years of unmatched achievement
30 . 09 .2021
Press release
RESTYLANE® celebrates 25 years of natural-looking results with its signature line of hyaluronic acid fillers
29 . 09 .2021
Press release
Galderma presents new nemolizumab data at EADV reinforcing rapid onset of action and consistent relief of symptoms for people with prurigo nodularis and atopic dermatitis
28 . 09 .2021
Press release
Galderma to unveil ground-breaking data from across its leading dermatology portfolio and showcase major update for sensitive skincare brand CETAPHIL® at the 2021 EADV Congress
27 . 09 .2021
Press release
Galderma and CETAPHIL® Announce Renewed Commitment to Environmental Sustainability and Social Impact Through New Clear Skies Initiative
23 . 09 .2021
Press release
Galderma announces exclusive agreement with Sofregen to develop the next generation of biostimulator fillers using silk-based technology
22 . 09 .2021
Press release
Cetaphil® Announces Major Evolution in Brand’s Mission to Advance Sensitive Skin Science
09 . 09 .2021
Press release
Galderma to present new data from leading aesthetics portfolio and launch RESTYLANE® EYELIGHT™ at AMWC 2021